Chief commercial officer Luke Miels to take over as CEO at UK-based pharmaceutical company
The pharmaceutical group GSK has announced the surprise departure of its chief executive, Emma Walmsley, after eight years in the top job.
Walmsley, who has run the FTSE 100 company since 2017, will step down from the board at the end of this year, and remain at the business until her notice period ends on 30 September 2026.